Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Deeks

Showing results (221-230 of 663) with videos related to

Pageof 67
Sort By:
Frontiers in Immunology|June 4, 2019
Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing AntibodiesJennie M Hutchinson, Kathryn A Mesa, David L Alexander, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2009
Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approachElvin H Geng, David R Bangsberg, Nicolas Musinguzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2020
Operationalizing Human Immunodeficiency Virus Cure-related Trials with Analytic Treatment Interruptions During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Collaborative ApproachMichael J Peluso, Lynda Dee, Shirley Shao, et al.
Journal of Virology|October 29, 2005
Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatmentBrinda Emu, Elizabeth Sinclair, David Favre, et al.
Virology|April 23, 2017
A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loadsPaige Charlins, Kimberly Schmitt, Leila Remling-Mulder, et al.
AIDS (London, England)|June 23, 2009
Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patientsPriscilla Y Hsue, Peter W Hunt, Yuaner Wu, et al.
Nature|May 7, 2010
Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infectionAndrej Kosmrlj, Elizabeth L Read, Ying Qi, et al.
Annals of the New York Academy of Sciences|December 2, 2016
Reverse geroscience: how does exposure to early diseases accelerate the age-related decline in health?Ronald A Kohanski, Steven G Deeks, Claudia Gravekamp, et al.
Frontiers in Immunology|February 13, 2023
Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4Katie Fisher, Timothy E Schlub, Zoe Boyer, et al.
Circulation. Heart Failure|November 26, 2009
Impact of HIV infection on diastolic function and left ventricular massPriscilla Y Hsue, Peter W Hunt, Jennifer E Ho, et al.
Pageof 67

Showing results (221-230 of 663) with videos related to

Sort By:
Pageof 67
Frontiers in Immunology|June 4, 2019
Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing AntibodiesJennie M Hutchinson, Kathryn A Mesa, David L Alexander, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2009
Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approachElvin H Geng, David R Bangsberg, Nicolas Musinguzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2020
Operationalizing Human Immunodeficiency Virus Cure-related Trials with Analytic Treatment Interruptions During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Collaborative ApproachMichael J Peluso, Lynda Dee, Shirley Shao, et al.
Journal of Virology|October 29, 2005
Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatmentBrinda Emu, Elizabeth Sinclair, David Favre, et al.
Virology|April 23, 2017
A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loadsPaige Charlins, Kimberly Schmitt, Leila Remling-Mulder, et al.
AIDS (London, England)|June 23, 2009
Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patientsPriscilla Y Hsue, Peter W Hunt, Yuaner Wu, et al.
Nature|May 7, 2010
Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infectionAndrej Kosmrlj, Elizabeth L Read, Ying Qi, et al.
Annals of the New York Academy of Sciences|December 2, 2016
Reverse geroscience: how does exposure to early diseases accelerate the age-related decline in health?Ronald A Kohanski, Steven G Deeks, Claudia Gravekamp, et al.
Frontiers in Immunology|February 13, 2023
Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4Katie Fisher, Timothy E Schlub, Zoe Boyer, et al.
Circulation. Heart Failure|November 26, 2009
Impact of HIV infection on diastolic function and left ventricular massPriscilla Y Hsue, Peter W Hunt, Jennifer E Ho, et al.
Pageof 67